Genital Warts Clinical Trials

Find Genital Warts Clinical Trials Near You

Treatment of Recurrent Genital Warts by Combination of CO2 Laser and Geniwa Gel

Status: Recruiting
Location: See location...
Intervention Type: Drug, Other
Study Type: Interventional
Study Phase: Phase 2
SUMMARY

Phase II, a randomized, double-blind, placebo-controlled clinical trial to evaluate the effectiveness and recurrence of genital warts by combination of CO2 laser and Geniwa gel compared to laser CO2 combined with gel placebo. The clinical trial is conducted at National Dermatology Hospital, Hanoi, Vietnam.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• 18 years of age or older.

• Able to read and understand the Patient Information Sheet and the Informed Consent form.

• Acceptance in the participation of the essay and signature of the Informed Consent form.

• Diagnosis of genital and anal warts with clear clinical manifestations.

• Have undergone at least 2 laser or nitrogen treatments and have experienced recurrence in any location.

• At least four or more lesions, or a lesion area of at least 0.5 cm2.

Locations
Other Locations
Viet Nam
National Dermatology Hospital, Hanoi, Vietnam.
RECRUITING
Hanoi
Contact Information
Primary
Thanh Tam Tran, MD
Tranthanhtam.fmh@gmail.com
+84383744842
Time Frame
Start Date: 2026-07-16
Estimated Completion Date: 2027-09-15
Participants
Target number of participants: 70
Treatments
Placebo_comparator: Combination of CO2 laser and placebo gel
Placebo gel contains saline gel
Experimental: Combination of CO2 laser and Geniwa gel
Geniwa gel contains 5% alpha lactalbumin-oleic acid complexes
Related Therapeutic Areas
Sponsors
Leads: KTH Biopharma

This content was sourced from clinicaltrials.gov